The Pharmacopoeia Commission of Indian Medicine and Homoeopathy (PCIM&H) may soon undertake development of pharmacopoeia standards for the Ayurveda, Siddha, Unani and Homoeopathy drugs under the ‘One Herb One Standard’ (OHOS) among other initiatives during the financial year 2023-24.
The Ministry of Ayush is also actively considering bringing of a legislation for regulation of Yoga and Naturopathy and a legislation for the Ayush Pharmacy and Allied Healthcare Professions, the ministry informed a Parliamentary panel.
The Ministry informed the Department Related Parliamentary Standing Committee on Health and Family Welfare that it is proposed to undertake various initiatives during the year 2023-24 including development of research and treatment infrastructure among other initiatives.
“During 2023-24, PCIM&H would undertake development of Pharmacopoeial standards of ASU&H drugs under “One Herb One Standard” and their publication, development of a Web portal for selling of soft copies of Pharmacopoeial Monographs as per GIGW (Guidelines for Indian Government Websites), publication of Single drugs/revised Monographs and formulations received under EoI (Expression of Interest) scheme of PCIM&H, development of CRM & BRS, NABL – ISO/IEC/17025:2018 Accreditation, the NABL accreditation of chemistry and microbiology laboratory, implementation of Integrated Management System (IMS) Certification and development of herbal garden in 10 Acre land,” the Ministry informed the panel.
“The Committee is of the considered view that the proposed legislations on Yoga & Naturopathy and Ayush Pharmacy, and Allied Healthcare Professions would play a pivotal role in the regulation of Ayush Industry and Professions and Yoga & Naturopathy. Keeping in view the rising popularity of the Ayush systems the proposed legislations are need of the hour. The Committee, therefore, recommends the Ministry to expedite the process of introducing of proposed legislation in the Parliament,” said the panel headed by Member of Parliament Bhubaneswar Kalita, in its report on Demands for Grants of the Ministry of Ayush for the year 2023-24.
Source : http://www.pharmabiz.com/NewsDetails.aspx?aid=157278&sid=1